SYK Stryker Corporation
Health Care · S&P 500
Next earnings: Thu 28 Jan 2027 · estimated
What 30 analyst firms say about Stryker Corporation: their latest ratings, price targets and how far the stock is from them. How it works
Analyst window: Latest analyst report within last 1 year
Analyst view · last 1Y
29 rated views · 33 analyst/firm records · 30 firms
Radar score
- S&P 500 · Top Picks · 6MBelow the Radar threshold of 8052
- S&P 500 · Safest consensus · 6MBelow the Radar threshold of 8067
Recent analyst activity · last 90 days
Our tracked history has 31 reports on SYK from 21 analyst firms in the last 90 days (30 firms in the past year).
Comparing each firm's latest target with its previous one: 16 lowered it and 1 left it unchanged.
Ratings, latest available report against the previous one: 0 upgrades and 2 downgrades.
Latest observed target change: Stifel lowered its target from $330.00 (set 30 Sep 2026) to $325.00 on 2 Nov 2026.
Last 1 year. Latest opinion per identifiable analyst within the last 1 year. BUY / HOLD / SELL each count one current analyst vote; unnamed firm records are a fallback.
| Firm | Analyst | Latest rating | Report date | Latest target (USD) |
|---|---|---|---|---|
| Argus | David A Toung | ConflictConflicting reports · excluded | 9 Jul 2026 | 370.00 USD |
| Baird | Jeffrey D Johnson | ConflictConflicting reports · excluded | 1 May 2026 | Conflicting reports · excluded |
| Barclays | Christopher Pasquale | Buy | 30 Oct 2026 | 365.00 USD |
| Bernstein | Lee Hambright | Buy | 31 Jul 2026 | 385.00 USD |
| BMO Capital Markets | Vikramjeet S Chopra | Buy | 30 Oct 2026 | 309.00 USD |
| BTIG | Ryan Zimmerman | Buy | 30 Oct 2026 | 304.00 USD |
| Canaccord Genuity | Caitlin Roberts | Hold | 30 Oct 2026 | 300.00 USD |
| Canaccord Genuity | Kyle Rose | Hold | 30 Oct 2026 | 300.00 USD |
| Citigroup | Joanne Wuensch | Buy | 30 Oct 2026 | Conflicting reports · excluded |
| Citizens JMP | Daniel Stauder | Buy | 30 Oct 2026 | 390.00 USD |
| Citizens JMP | David Turkaly | Buy | 3 Aug 2026 | 400.00 USD |
| Deutsche Bank | Unnamed analyst | — | 1 May 2026 | 315.00 USD |
| Evercore ISI | Vijay Kumar | Buy | 6 Oct 2026 | Conflicting reports · excluded |
| Goldman Sachs | David Roman | Hold | 1 May 2026 | Conflicting reports · excluded |
| Jefferies | Matthew C Taylor | Buy | 30 Oct 2026 | 390.00 USD |
| Johnson Rice | Unnamed analyst | Hold | 30 Oct 2026 | — |
| JPMorgan | Robbie Marcus | Buy | 31 Jul 2026 | 350.00 USD |
| Leerink Partners | Michael Kratky | Buy | 18 Aug 2026 | 353.00 USD |
| Needham | Mike Matson | Buy | 30 Oct 2026 | 359.00 USD |
| Piper Sandler | Matt O'Brien | Buy | 31 Jul 2026 | 390.00 USD |
| Raymond James | Jayson Bedford | Buy | 30 Oct 2026 | 323.00 USD |
| RBC Capital Markets | Kendall Au | Buy | 30 Oct 2026 | 375.00 USD |
| Redburn | Ed Ridley-Day | Hold | 13 May 2026 | 360.00 USD |
| Stifel | Rick Wise | Buy | 30 Sep 2026 | 330.00 USD |
| TD Cowen | Mathew Blackman | Hold | 30 Oct 2026 | 290.00 USD |
| Truist | Richard Newitter | Hold | 6 Oct 2026 | Conflicting reports · excluded |
| UBS | Danielle Antalffy | Buy | 28 Jul 2026 | 400.00 USD |
| UBS | Patrick Wood | Buy | 28 Jul 2026 | 382.00 USD |
| Weiss Ratings | Unnamed analyst | — | 29 Oct 2026 | — |
| Wells Fargo | Larry Biegelsen | Buy | 9 Sep 2026 | 348.00 USD |
| William Blair | Steven Lichtman | Buy | 31 Jul 2026 | — |
| Wolfe Research | Mike Polark | Hold | 13 Aug 2026 | — |
| Data feed RESEARCH | Research Team | Hold | 15 May 2026 | 291.00 USD |
Partial coverage · checked 6 Nov (6 Nov 2026, 04:02 ET). Some research records could not be refreshed. Cached records retained. Prices stream live during the US session; otherwise stored prices delayed about 15 minutes. A summary of analyst opinion, not investment advice.